Metabolic dysregulation, particularly in the context of obesity, compounds these effects by fostering a pro-inflammatory milieu characterized by increased levels of leptin, adiponectin, interleukin-6 (IL-6), and TNF-α [32,33]. The gene discussed is IL6; the disease is obesity disorder.